Richard, The approach of using an antibody to a drug to explore intra-cellular distribution will only generate reliable data if (1) the antibody enters the cell, (2) antibody binding does not relaese the drug from the target(s), (3) the antibody-drug complex has 'the same' affinity for the target(s). Permeabilization of the cells after the drug incubation will most likely destroy the drug-target complexes and thus yield unreliable data. However, you may consider permeabilization/antibody loading of the cells prior to the drug incubation. If you trap a sufficient number of antibody molecules and they distribute randomly in the cell, this procedure may yield reliable data. Another approach would be to tag the drug with FITC. And finally, you could tag the drug with an azido group, which allows you to cross-link the drug to the target(s) after the appropriate incubation time. You can then permeabilze the cells and use the antibody to analyze the drug distribution. Jan. >---------- >From: Richard K. Meister >Sent: Wednesday, May 28, 1997 3:20 PM >To: cyto-inbox >Subject: Drug studies > > >Hi, everyone: > >I have an investigator who wants to look at intracellular distribution of a >drug using confocal laser scanning microscopy. The drug is not fluorescent, >so he has a monoclonal antibody (FITC conjugate) to the drug. Our question >is, during permeablization to allow the antibody into the cells, what is the >best way to prevent the drug from leaching out of the cells? I suppose a >pre-permeablization paraformaldehyde fixation step would be helpful, but I >would like to hear from anyone who has done such drug studies and knows if >this is an effective approach. > >Thanks in advance. J.F. Keij Los Alamos National Laboratory LS-5, MS M888 Los Alamos, NM 87545 tel (505)-667-3526 fax (505)-665-6894 e-mail keij@lanl.gov
This archive was generated by hypermail 2b29 : Wed Apr 03 2002 - 11:49:48 EST